Solid Tumors

Beyond Air have developed a proprietary system for the administration of nitric oxide at ultra-high concentrations directly to solid tumors. Please see our abstract “Gaseous Nitric Oxide at high concentration is a powerful anti-tumor agent both in-vitro and in-vivo” here, submitted to the American Association for Cancer Research Virtual Annual Meeting II on June 22^nd 2020.

Product Status and Market Potential

Beyond Air Pipeline & Market Size

Product	Indication	Development Status	Key Dates^*	US Sales Potential^**	Worldwide Sales Potential^**
Solid Tumors	Multiple solid tumors	Pre-clinical	Initial data 2Q20	TBD	TBD

Nitri*All dates are based on projections and appropriate financing, anticipated first launch on global basis pending appropriate regulatory approvals

**All figures are Company estimates for peak year sales: Global Sales Potential includes US Sales Potential

Important Safety Information

^†Caution - LungFit is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use.